torsemide has been researched along with arsenic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, R; Hai, X; Lv, J; Pang, C; Tian, S; Wu, M; Yang, H; Zhang, H | 1 |
1 other study(ies) available for torsemide and arsenic
| Article | Year |
|---|---|
Torsemide increases arsenic concentrations by inhibition of multidrug resistance protein 4 in arsenic trioxide treated acute promyelocytic leukemia patients.
Topics: Animals; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Drug Resistance, Multiple; HEK293 Cells; Humans; Leukemia, Promyelocytic, Acute; Multidrug Resistance-Associated Proteins; Oxides; Rats; Torsemide | 2023 |